SL Science Holding Ltd(SLBT)

Biotechnology · Taipei, NY

$1.52-0.07 (-4.40%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Compare

Interest Coverage Ratio: N/A

Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.

The interest coverage ratio is N/A as of Tuesday, October 6, 2026.

Interest Expense|Total Debt|Debt/Equity|Operating Margin|All Metrics

SLBT Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

N/A

SLBT Competitors' Interest Coverage Ratio

SLBT

SL Science Holding Ltd

Current

Market Cap

$852.35M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RIGL

Rigel Pharmaceuticals, Inc.

vs SLBT

Market Cap

$853.13M

Interest Coverage Ratio

17.14x

TTM Avg

10.10x

3Y Avg

10.10x

5Y Avg

10.10x

ALMS

Alumis Inc.

vs SLBT

Market Cap

$855.38M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QDEL

QuidelOrtho Corporation

vs SLBT

Market Cap

$857.16M

Interest Coverage Ratio

-5.18x

TTM Avg

6.05x

3Y Avg

536.48x

5Y Avg

359.36x

PACB

Pacific Biosciences of California, Inc.

vs SLBT

Market Cap

$838.62M

Interest Coverage Ratio

-80.18x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BBNX

Beta Bionics, Inc.

vs SLBT

Market Cap

$838.16M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SIBN

SI-BONE, Inc.

vs SLBT

Market Cap

$867.03M

Interest Coverage Ratio

-4.23x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ODTX

Odyssey Therapeutics, Inc.

vs SLBT

Market Cap

$870.81M

Interest Coverage Ratio

-9479.76x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GLUE

Monte Rosa Therapeutics, Inc.

vs SLBT

Market Cap

$833.81M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SGP

SpyGlass Pharma, Inc. Common Stock

vs SLBT

Market Cap

$828.48M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
SL Science Holding Ltd (SLBT)	$852.35M	N/A	N/A	N/A	N/A
Rigel Pharmaceuticals, Inc. (RIGL)vs ›	$853.13M	17.14x	10.10x	10.10x	10.10x
Alumis Inc. (ALMS)vs ›	$855.38M	N/A	N/A	N/A	N/A
QuidelOrtho Corporation (QDEL)vs ›	$857.16M	-5.18x	6.05x	536.48x	359.36x
Pacific Biosciences of California, Inc. (PACB)vs ›	$838.62M	-80.18x	N/A	N/A	N/A
Beta Bionics, Inc. (BBNX)vs ›	$838.16M	N/A	N/A	N/A	N/A
SI-BONE, Inc. (SIBN)vs ›	$867.03M	-4.23x	N/A	N/A	N/A
Odyssey Therapeutics, Inc. (ODTX)vs ›	$870.81M	-9479.76x	N/A	N/A	N/A
Monte Rosa Therapeutics, Inc. (GLUE)vs ›	$833.81M	N/A	N/A	N/A	N/A
SpyGlass Pharma, Inc. Common Stock (SGP)vs ›	$828.48M	N/A	N/A	N/A	N/A

Financial Health Indicators

Interest Coverage

N/A

Debt/Equity

0.09

Current Ratio

3.05

Formula: Interest Coverage = EBIT / Interest Expense

Reference ranges:

< 1.5x: EBIT is less than 1.5 times interest expense
1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
3x - 5x: EBIT is between 3 and 5 times interest expense
> 5x: EBIT is more than 5 times interest expense

Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.

Interest Coverage Ratio Formula & Definition

Interest Coverage = EBIT / Interest Expense

The interest coverage ratio measures operating earnings relative to interest expense.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Interest Coverage Ratio: N/A

SLBT Interest Coverage Ratio Metrics

SLBT Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Related Metrics